Active Pharmaceutical Ingredient (API) Market in India 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	175 Pages	TechNavio	March, 2025	INF19892466

Best Price Guarantee
Price	from $2,500
Length	175 Pages
Publisher	TechNavio
Published Date	March, 2025
SKU	INF19892466

Active Pharmaceutical Ingredient (API) Market In India 2025-2029

The active pharmaceutical ingredient (API) market in India is forecasted to grow by USD 11184 million during 2024-2029, accelerating at a CAGR of 7.4% during the forecast period. The report on the active pharmaceutical ingredient (API) market in India provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing number of type ii drug master files (DMF), growing emphasis on biosimilars manufacturing, and growing need to focus on core competencies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's active pharmaceutical ingredient (API) market in India is segmented as below:

By Manufacturing Type

Captive APIs
Contract APIs

By Type

Innovative APIs
Generic APIs

By Product Type

Prescription
Over-the-counter (OTC)

By Application

Cardiovascular diseases (CVDs)
Oncology
Infectious diseases
Diabetes
Others

By Geographical Landscape

APAC

This study identifies the paradigm shift in API manufacturing as one of the prime reasons driving the active pharmaceutical ingredient (API) market in India growth during the next few years. Also, increasing patent exercises and adoption of sustainable and environmentally friendly manufacturing practices will lead to sizable demand in the market.

The report on the active pharmaceutical ingredient (API) market in India covers the following areas:

Active Pharmaceutical Ingredient (API) Market in India sizing
Active Pharmaceutical Ingredient (API) Market in India forecast
Active Pharmaceutical Ingredient (API) Market in India industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading active pharmaceutical ingredient (API) market in India vendors that include AbbVie Inc., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., Cipla Inc., Divis Laboratories Ltd., DR Reddys Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Granules India Ltd., Hetero Labs Ltd., Ind-Swift Laboratories Ltd., IOL Chemicals and Pharmaceuticals Ltd., Ipca Laboratories, J. B. Chemicals and Pharmaceuticals Ltd, Jubilant Pharmova Ltd., Laurus Labs Ltd., Lupin Ltd., Solara Active Pharma Sciences Ltd, Sun Pharmaceutical Industries Ltd., SUVEN PHARMACEUTICALS LTD., and Torrent Pharmaceuticals Ltd.. Also, the active pharmaceutical ingredient (API) market in India analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Country Market Characteristics; Executive Summary - Chart on Market Segmentation by Manufacturing Type; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by Product Type; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ million); Data Table on India - Market size and forecast 2024-2029 ($ million); Chart on India: Year-over-year growth 2024-2029 (%); Data Table on India: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Active Pharmaceutical Ingredient (API) Market in India 2019 - 2023; Historic Market Size - Data Table on Active Pharmaceutical Ingredient (API) Market in India 2019 - 2023 ($ million); 5.2 Manufacturing Type segment analysis 2019 - 2023; Historic Market Size - Manufacturing Type Segment 2019 - 2023 ($ million); 5.3 Type segment analysis 2019 - 2023; Historic Market Size - Type Segment 2019 - 2023 ($ million); 5.4 Product Type segment analysis 2019 - 2023; Historic Market Size - Product Type Segment 2019 - 2023 ($ million); 5.5 Application segment analysis 2019 - 2023; Historic Market Size - Application Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 Impact of AI on Active Pharmaceutical Ingredient (API) Market in India
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Manufacturing Type: 8.1 Market segments; Chart on Manufacturing Type - Market share 2024-2029 (%); Data Table on Manufacturing Type - Market share 2024-2029 (%); 8.2 Comparison by Manufacturing Type; Chart on Comparison by Manufacturing Type; Data Table on Comparison by Manufacturing Type; 8.3 Captive APIs - Market size and forecast 2024-2029; Chart on Captive APIs - Market size and forecast 2024-2029 ($ million); Data Table on Captive APIs - Market size and forecast 2024-2029 ($ million); Chart on Captive APIs - Year-over-year growth 2024-2029 (%); Data Table on Captive APIs - Year-over-year growth 2024-2029 (%); 8.4 Contract APIs - Market size and forecast 2024-2029; Chart on Contract APIs - Market size and forecast 2024-2029 ($ million); Data Table on Contract APIs - Market size and forecast 2024-2029 ($ million); Chart on Contract APIs - Year-over-year growth 2024-2029 (%); Data Table on Contract APIs - Year-over-year growth 2024-2029 (%); 8.5 Market opportunity by Manufacturing Type; Market opportunity by Manufacturing Type ($ million); Data Table on Market opportunity by Manufacturing Type ($ million)
9 Market Segmentation by Type: 9.1 Market segments; Chart on Type - Market share 2024-2029 (%); Data Table on Type - Market share 2024-2029 (%); 9.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 9.3 Innovative APIs - Market size and forecast 2024-2029; Chart on Innovative APIs - Market size and forecast 2024-2029 ($ million); Data Table on Innovative APIs - Market size and forecast 2024-2029 ($ million); Chart on Innovative APIs - Year-over-year growth 2024-2029 (%); Data Table on Innovative APIs - Year-over-year growth 2024-2029 (%); 9.4 Generic APIs - Market size and forecast 2024-2029; Chart on Generic APIs - Market size and forecast 2024-2029 ($ million); Data Table on Generic APIs - Market size and forecast 2024-2029 ($ million); Chart on Generic APIs - Year-over-year growth 2024-2029 (%); Data Table on Generic APIs - Year-over-year growth 2024-2029 (%); 9.5 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
10 Market Segmentation by Product Type: 10.1 Market segments; Chart on Product Type - Market share 2024-2029 (%); Data Table on Product Type - Market share 2024-2029 (%); 10.2 Comparison by Product Type; Chart on Comparison by Product Type; Data Table on Comparison by Product Type; 10.3 Prescription - Market size and forecast 2024-2029; Chart on Prescription - Market size and forecast 2024-2029 ($ million); Data Table on Prescription - Market size and forecast 2024-2029 ($ million); Chart on Prescription - Year-over-year growth 2024-2029 (%); Data Table on Prescription - Year-over-year growth 2024-2029 (%); 10.4 Over-the-counter (OTC) - Market size and forecast 2024-2029; Chart on Over-the-counter (OTC) - Market size and forecast 2024-2029 ($ million); Data Table on Over-the-counter (OTC) - Market size and forecast 2024-2029 ($ million); Chart on Over-the-counter (OTC) - Year-over-year growth 2024-2029 (%); Data Table on Over-the-counter (OTC) - Year-over-year growth 2024-2029 (%); 10.5 Market opportunity by Product Type; Market opportunity by Product Type ($ million); Data Table on Market opportunity by Product Type ($ million)
11 Market Segmentation by Application: 11.1 Market segments; Chart on Application - Market share 2024-2029 (%); Data Table on Application - Market share 2024-2029 (%); 11.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 11.3 Cardiovascular diseases (CVDs) - Market size and forecast 2024-2029; Chart on Cardiovascular diseases (CVDs) - Market size and forecast 2024-2029 ($ million); Data Table on Cardiovascular diseases (CVDs) - Market size and forecast 2024-2029 ($ million); Chart on Cardiovascular diseases (CVDs) - Year-over-year growth 2024-2029 (%); Data Table on Cardiovascular diseases (CVDs) - Year-over-year growth 2024-2029 (%); 11.4 Oncology - Market size and forecast 2024-2029; Chart on Oncology - Market size and forecast 2024-2029 ($ million); Data Table on Oncology - Market size and forecast 2024-2029 ($ million); Chart on Oncology - Year-over-year growth 2024-2029 (%); Data Table on Oncology - Year-over-year growth 2024-2029 (%); 11.5 Infectious diseases - Market size and forecast 2024-2029; Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million); Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million); Chart on Infectious diseases - Year-over-year growth 2024-2029 (%); Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%); 11.6 Diabetes - Market size and forecast 2024-2029; Chart on Diabetes - Market size and forecast 2024-2029 ($ million); Data Table on Diabetes - Market size and forecast 2024-2029 ($ million); Chart on Diabetes - Year-over-year growth 2024-2029 (%); Data Table on Diabetes - Year-over-year growth 2024-2029 (%); 11.7 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ million); Data Table on Others - Market size and forecast 2024-2029 ($ million); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 11.8 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
12 Customer Landscape: 12.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Drivers, Challenges, and Opportunity/Restraints: 13.1 Market drivers; 13.2 Market challenges; 13.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 13.4 Market opportunities/restraints
14 Competitive Landscape: 14.1 Overview; 14.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 14.3 Landscape disruption; Overview on factors of disruption; 14.4 Industry risks; Impact of key risks on business
15 Competitive Analysis: 15.1 Companies profiled; Companies covered; 15.2 Company ranking index; Company ranking index; 15.3 Market positioning of companies; Matrix on companies position and classification; 15.4 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; SWOT; 15.5 Aurobindo Pharma Ltd.; Aurobindo Pharma Ltd. - Overview; Aurobindo Pharma Ltd. - Product / Service; Aurobindo Pharma Ltd. - Key offerings; SWOT; 15.6 Cadila Pharmaceuticals Ltd.; Cadila Pharmaceuticals Ltd. - Overview; Cadila Pharmaceuticals Ltd. - Product / Service; Cadila Pharmaceuticals Ltd. - Key offerings; SWOT; 15.7 Cipla Inc.; Cipla Inc. - Overview; Cipla Inc. - Business segments; Cipla Inc. - Key news; Cipla Inc. - Key offerings; Cipla Inc. - Segment focus; SWOT; 15.8 Divis Laboratories Ltd.; Divis Laboratories Ltd. - Overview; Divis Laboratories Ltd. - Product / Service; Divis Laboratories Ltd. - Key offerings; SWOT; 15.9 Dr Reddys Laboratories Ltd.; Dr Reddys Laboratories Ltd. - Overview; Dr Reddys Laboratories Ltd. - Business segments; Dr Reddys Laboratories Ltd. - Key news; Dr Reddys Laboratories Ltd. - Key offerings; Dr Reddys Laboratories Ltd. - Segment focus; SWOT; 15.10 Glenmark Pharmaceuticals Ltd.; Glenmark Pharmaceuticals Ltd. - Overview; Glenmark Pharmaceuticals Ltd. - Product / Service; Glenmark Pharmaceuticals Ltd. - Key offerings; SWOT; 15.11 Granules India Ltd.; Granules India Ltd. - Overview; Granules India Ltd. - Product / Service; Granules India Ltd. - Key news; Granules India Ltd. - Key offerings; SWOT; 15.12 IOL Chemicals and Pharmaceuticals Ltd.; IOL Chemicals and Pharmaceuticals Ltd. - Overview; IOL Chemicals and Pharmaceuticals Ltd. - Business segments; IOL Chemicals and Pharmaceuticals Ltd. - Key offerings; IOL Chemicals and Pharmaceuticals Ltd. - Segment focus; SWOT; 15.13 Ipca Laboratories; Ipca Laboratories - Overview; Ipca Laboratories - Product / Service; Ipca Laboratories - Key offerings; SWOT; 15.14 Jubilant Pharmova Ltd.; Jubilant Pharmova Ltd. - Overview; Jubilant Pharmova Ltd. - Business segments; Jubilant Pharmova Ltd. - Key news; Jubilant Pharmova Ltd. - Key offerings; Jubilant Pharmova Ltd. - Segment focus; SWOT; 15.15 Laurus Labs Ltd.; Laurus Labs Ltd. - Overview; Laurus Labs Ltd. - Product / Service; Laurus Labs Ltd. - Key offerings; SWOT; 15.16 Lupin Ltd.; Lupin Ltd. - Overview; Lupin Ltd. - Business segments; Lupin Ltd. - Key news; Lupin Ltd. - Key offerings; Lupin Ltd. - Segment focus; SWOT; 15.17 Sun Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd. - Overview; Sun Pharmaceutical Industries Ltd. - Product / Service; Sun Pharmaceutical Industries Ltd. - Key news; Sun Pharmaceutical Industries Ltd. - Key offerings; SWOT; 15.18 Torrent Pharmaceuticals Ltd.; Torrent Pharmaceuticals Ltd. - Overview; Torrent Pharmaceuticals Ltd. - Business segments; Torrent Pharmaceuticals Ltd. - Key offerings; Torrent Pharmaceuticals Ltd. - Segment focus; SWOT
16 Appendix: 16.1 Scope of the report; 16.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 16.3 Currency conversion rates for US$; Currency conversion rates for US$; 16.4 Research methodology; Research methodology; 16.5 Data procurement; Information sources; 16.6 Data validation; Data validation; 16.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 16.8 Data synthesis; Data synthesis; 16.9 360 degree market analysis; 360 degree market analysis; 16.10 List of abbreviations; List of abbreviations; Exhibits:; Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market Segmentation by Manufacturing Type; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by Product Type; Exhibits7: Executive Summary - Chart on Market Segmentation by Application; Exhibits8: Executive Summary - Chart on Company Market Positioning; Exhibits9: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits10: Overview on criticality of inputs and factors of differentiation; Exhibits11: Overview on factors of disruption; Exhibits12: Impact of drivers and challenges in 2024 and 2029; Exhibits13: Parent Market; Exhibits14: Data Table on - Parent Market; Exhibits15: Market characteristics analysis; Exhibits16: Value chain analysis; Exhibits17: Offerings of companies included in the market definition; Exhibits18: Market segments; Exhibits19: Chart on India - Market size and forecast 2024-2029 ($ million); Exhibits20: Data Table on India - Market size and forecast 2024-2029 ($ million); Exhibits21: Chart on India: Year-over-year growth 2024-2029 (%); Exhibits22: Data Table on India: Year-over-year growth 2024-2029 (%); Exhibits23: Historic Market Size - Data Table on Active Pharmaceutical Ingredient (API) Market in India 2019 - 2023 ($ million); Exhibits24: Historic Market Size - Manufacturing Type Segment 2019 - 2023 ($ million); Exhibits25: Historic Market Size - Type Segment 2019 - 2023 ($ million); Exhibits26: Historic Market Size - Product Type Segment 2019 - 2023 ($ million); Exhibits27: Historic Market Size - Application Segment 2019 - 2023 ($ million); Exhibits28: Five forces analysis - Comparison between 2024 and 2029; Exhibits29: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits30: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits31: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits32: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits33: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits34: Chart on Market condition - Five forces 2024 and 2029; Exhibits35: Chart on Manufacturing Type - Market share 2024-2029 (%); Exhibits36: Data Table on Manufacturing Type - Market share 2024-2029 (%); Exhibits37: Chart on Comparison by Manufacturing Type; Exhibits38: Data Table on Comparison by Manufacturing Type; Exhibits39: Chart on Captive APIs - Market size and forecast 2024-2029 ($ million); Exhibits40: Data Table on Captive APIs - Market size and forecast 2024-2029 ($ million); Exhibits41: Chart on Captive APIs - Year-over-year growth 2024-2029 (%); Exhibits42: Data Table on Captive APIs - Year-over-year growth 2024-2029 (%); Exhibits43: Chart on Contract APIs - Market size and forecast 2024-2029 ($ million); Exhibits44: Data Table on Contract APIs - Market size and forecast 2024-2029 ($ million); Exhibits45: Chart on Contract APIs - Year-over-year growth 2024-2029 (%); Exhibits46: Data Table on Contract APIs - Year-over-year growth 2024-2029 (%); Exhibits47: Market opportunity by Manufacturing Type ($ million); Exhibits48: Data Table on Market opportunity by Manufacturing Type ($ million); Exhibits49: Chart on Type - Market share 2024-2029 (%); Exhibits50: Data Table on Type - Market share 2024-2029 (%); Exhibits51: Chart on Comparison by Type; Exhibits52: Data Table on Comparison by Type; Exhibits53: Chart on Innovative APIs - Market size and forecast 2024-2029 ($ million); Exhibits54: Data Table on Innovative APIs - Market size and forecast 2024-2029 ($ million); Exhibits55: Chart on Innovative APIs - Year-over-year growth 2024-2029 (%); Exhibits56: Data Table on Innovative APIs - Year-over-year growth 2024-2029 (%); Exhibits57: Chart on Generic APIs - Market size and forecast 2024-2029 ($ million); Exhibits58: Data Table on Generic APIs - Market size and forecast 2024-2029 ($ million); Exhibits59: Chart on Generic APIs - Year-over-year growth 2024-2029 (%); Exhibits60: Data Table on Generic APIs - Year-over-year growth 2024-2029 (%); Exhibits61: Market opportunity by Type ($ million); Exhibits62: Data Table on Market opportunity by Type ($ million); Exhibits63: Chart on Product Type - Market share 2024-2029 (%); Exhibits64: Data Table on Product Type - Market share 2024-2029 (%); Exhibits65: Chart on Comparison by Product Type; Exhibits66: Data Table on Comparison by Product Type; Exhibits67: Chart on Prescription - Market size and forecast 2024-2029 ($ million); Exhibits68: Data Table on Prescription - Market size and forecast 2024-2029 ($ million); Exhibits69: Chart on Prescription - Year-over-year growth 2024-2029 (%); Exhibits70: Data Table on Prescription - Year-over-year growth 2024-2029 (%); Exhibits71: Chart on Over-the-counter (OTC) - Market size and forecast 2024-2029 ($ million); Exhibits72: Data Table on Over-the-counter (OTC) - Market size and forecast 2024-2029 ($ million); Exhibits73: Chart on Over-the-counter (OTC) - Year-over-year growth 2024-2029 (%); Exhibits74: Data Table on Over-the-counter (OTC) - Year-over-year growth 2024-2029 (%); Exhibits75: Market opportunity by Product Type ($ million); Exhibits76: Data Table on Market opportunity by Product Type ($ million); Exhibits77: Chart on Application - Market share 2024-2029 (%); Exhibits78: Data Table on Application - Market share 2024-2029 (%); Exhibits79: Chart on Comparison by Application; Exhibits80: Data Table on Comparison by Application; Exhibits81: Chart on Cardiovascular diseases (CVDs) - Market size and forecast 2024-2029 ($ million); Exhibits82: Data Table on Cardiovascular diseases (CVDs) - Market size and forecast 2024-2029 ($ million); Exhibits83: Chart on Cardiovascular diseases (CVDs) - Year-over-year growth 2024-2029 (%); Exhibits84: Data Table on Cardiovascular diseases (CVDs) - Year-over-year growth 2024-2029 (%); Exhibits85: Chart on Oncology - Market size and forecast 2024-2029 ($ million); Exhibits86: Data Table on Oncology - Market size and forecast 2024-2029 ($ million); Exhibits87: Chart on Oncology - Year-over-year growth 2024-2029 (%); Exhibits88: Data Table on Oncology - Year-over-year growth 2024-2029 (%); Exhibits89: Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million); Exhibits90: Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million); Exhibits91: Chart on Infectious diseases - Year-over-year growth 2024-2029 (%); Exhibits92: Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%); Exhibits93: Chart on Diabetes - Market size and forecast 2024-2029 ($ million); Exhibits94: Data Table on Diabetes - Market size and forecast 2024-2029 ($ million); Exhibits95: Chart on Diabetes - Year-over-year growth 2024-2029 (%); Exhibits96: Data Table on Diabetes - Year-over-year growth 2024-2029 (%); Exhibits97: Chart on Others - Market size and forecast 2024-2029 ($ million); Exhibits98: Data Table on Others - Market size and forecast 2024-2029 ($ million); Exhibits99: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits100: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits101: Market opportunity by Application ($ million); Exhibits102: Data Table on Market opportunity by Application ($ million); Exhibits103: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits104: Impact of drivers and challenges in 2024 and 2029; Exhibits105: Overview on criticality of inputs and factors of differentiation; Exhibits106: Overview on factors of disruption; Exhibits107: Impact of key risks on business; Exhibits108: Companies covered; Exhibits109: Company ranking index; Exhibits110: Matrix on companies position and classification; Exhibits111: AbbVie Inc. - Overview; Exhibits112: AbbVie Inc. - Product / Service; Exhibits113: AbbVie Inc. - Key news; Exhibits114: AbbVie Inc. - Key offerings; Exhibits115: SWOT; Exhibits116: Aurobindo Pharma Ltd. - Overview; Exhibits117: Aurobindo Pharma Ltd. - Product / Service; Exhibits118: Aurobindo Pharma Ltd. - Key offerings; Exhibits119: SWOT; Exhibits120: Cadila Pharmaceuticals Ltd. - Overview; Exhibits121: Cadila Pharmaceuticals Ltd. - Product / Service; Exhibits122: Cadila Pharmaceuticals Ltd. - Key offerings; Exhibits123: SWOT; Exhibits124: Cipla Inc. - Overview; Exhibits125: Cipla Inc. - Business segments; Exhibits126: Cipla Inc. - Key news; Exhibits127: Cipla Inc. - Key offerings; Exhibits128: Cipla Inc. - Segment focus; Exhibits129: SWOT; Exhibits130: Divis Laboratories Ltd. - Overview; Exhibits131: Divis Laboratories Ltd. - Product / Service; Exhibits132: Divis Laboratories Ltd. - Key offerings; Exhibits133: SWOT; Exhibits134: Dr Reddys Laboratories Ltd. - Overview; Exhibits135: Dr Reddys Laboratories Ltd. - Business segments; Exhibits136: Dr Reddys Laboratories Ltd. - Key news; Exhibits137: Dr Reddys Laboratories Ltd. - Key offerings; Exhibits138: Dr Reddys Laboratories Ltd. - Segment focus; Exhibits139: SWOT